Skip to main navigation Skip to search Skip to main content

TH-302 - ein neues unter Hypoxie aktiviertes Zytostatikum beim Pankreaskarzinom

Translated title of the contribution: TH-302 - a new hypoxia-activated cytostatic agent in pancreatic cancer treatment

Claudia Schmalz, Jürgen Dunst

Translated title of the contributionTH-302 - a new hypoxia-activated cytostatic agent in pancreatic cancer treatment
Original languageGerman
JournalStrahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Volume191
Issue number10
Pages (from-to)819-820
Number of pages2
ISSN0179-7158
DOIs
Publication statusPublished - 01.10.2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this